NuGen Medical Devices Inc (NGMD) — Cash Flow-to-Debt Ratio
NuGen Medical Devices Inc (NGMD) has a Cash Flow-to-Debt Ratio of -0.06x as of September 2025, meaning its operating cash flow of CA$-1.05 Million could theoretically repay 0% of its total liabilities (CA$18.85 Million) in one year. See working capital position of NuGen Medical Devices Inc to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NuGen Medical Devices Inc Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for NuGen Medical Devices Inc across 5 annual periods. Also explore NGMD year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for NuGen Medical Devices Inc (2020–2024)
Year-by-year debt coverage analysis for NuGen Medical Devices Inc. For market capitalisation and broader financial context, see NuGen Medical Devices Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.25x | CA$-4.71 Million | CA$18.57 Million | ▲ +65.9% |
| 2023 | -0.75x | CA$-6.71 Million | CA$9.01 Million | ▼ -39.1% |
| 2022 | -0.54x | CA$-4.88 Million | CA$9.11 Million | ▲ +6.0% |
| 2021 | -0.57x | CA$-4.10 Million | CA$7.19 Million | ▼ -523.7% |
| 2020 | -0.09x | CA$-1.39 Million | CA$15.25 Million | — |